Skip to main content
Fagron N.V. logo

Fagron N.V. — Investor Relations & Filings

Ticker · FAGR ISIN · BE0003874915 LEI · 549300TRKRUFK2RRG779 BR Manufacturing
Filings indexed 1,987 across all filing types
Latest filing 2025-07-31 Interim / Quarterly Rep…
Country BE Belgium
Listing BR FAGR

About Fagron N.V.

https://fagron.com/

Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.

Recent filings

Filing Released Lang Actions
Fagron - H1 2025 PR NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half (H1) of 2025, detailing financial performance, regional results, operational highlights, and management commentary. It contains substantive financial data, tables, and analysis, which distinguishes it from a simple earnings release or a report publication announcement. It is a formal interim report covering a period shorter than a full fiscal year. H1 2025
2025-07-31 Dutch
Fagron - IFS 30-07-2025 EN.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Financial Statements' for the 'First Half Year of 2025'. It contains comprehensive financial data, including a condensed consolidated income statement, statement of financial position, cash flow statement, and notes to the interim financial information. It is not a short announcement or a certification, but the actual financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-07-31 English
Fagron - IFS 30-07-2025 NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Tussentijdse financiële informatie' (Interim financial information) for the first half of 2025. It contains comprehensive financial statements, including a consolidated income statement, balance sheet, cash flow statement, and detailed notes to the financial statements. It is not a mere announcement or certification, but the actual interim report itself. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-07-31 Dutch
Fagron - H1 2025 PR EN.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive H1 2025 financial results announcement for Fagron. It contains detailed financial tables (revenue, REBITDA, EPS, cash flow), regional business reviews, management commentary, and outlook statements. While it mentions that interim financial statements are available on the website, the document itself provides the substantive financial data and analysis for the six-month period, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-07-31 English
Fagron - H1 2025 PR NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half (H1) of 2025, detailing financial performance, regional results, operational highlights, and management commentary. It contains substantive financial data, tables, and analysis, which distinguishes it from a simple earnings release or a report publication announcement. It is a formal interim report covering a period shorter than a full fiscal year. H1 2025
2025-07-31 Dutch
Disclosure of notification received from Alychlo
Major Shareholding Notification Classification · 99% confidence The document is a formal announcement dated July 18, 2025, detailing the receipt of a notification from Alychlo NV regarding a change in their shareholding interest in Fagron, specifically crossing a notification threshold (3%) due to the sale of voting rights. This type of filing, which reports personal share transactions by executives or significant changes in ownership crossing regulatory thresholds, aligns best with the 'Major Shareholding Notification' (MRQ) definition, as it concerns changes in significant share ownership levels. It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as it pertains to a specific insider/major shareholder disclosure. Given the content explicitly discusses the notification of a major shareholder crossing a threshold, MRQ is the most precise classification.
2025-07-21 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.